Beyond the ‘MITF-low’ microRNAs, we found a trend towards higher miR-146a-5p expression in melanomas that did not receive clinical benefit, although this result did not reach statistical significance, possibly due to the small cohort size. This evidence concerns the gene MITF and melanoma.